Indoco Remedies is expected to report top-line growth of 20.8% to Rs. 183cr.The OPM is expected to expand by 10bps yoy to 13.8%.As a result, net profit is expected to increase by 39.1% yoy to Rs. 14.4cr.
We maintain our buy with a target price of Rs. 78.
